FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
3.240
-0.030 (-0.92%)
At close: Sep 18, 2024, 4:00 PM
3.250
+0.010 (0.31%)
After-hours: Sep 18, 2024, 4:45 PM EDT
FibroBiologics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
10
Market Cap
114.24M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionFBLG News
- 6 days ago - FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology - GlobeNewsWire
- 12 days ago - FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 4 weeks ago - FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology - GlobeNewsWire
- 6 weeks ago - FibroBiologics Files 2024 Second Quarter Report - GlobeNewsWire
- 2 months ago - FibroBiologics to Present at JonesTrading Healthcare Summit 2024 - GlobeNewsWire
- 3 months ago - FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology - GlobeNewsWire
- 3 months ago - FibroBiologics Set to Join Russell 2000® Index - GlobeNewsWire
- 3 months ago - FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024 - GlobeNewsWire